About Us
Platform
Pipeline
Team
Resources
Contact

Paul Garofolo

May 8, 2025

By Nate Finger

  • Privacy Policy

Kinvard Bio ©2025. 
All rights reserved.

Privacy Policy

Kinvard Bio Website Privacy Policy

Last modified:  March 4, 2025

Kinvard Bio (“we,” “us,” or “our”) created the following Website Privacy Policy to describe the type of information we may collect from you when you visit our website, www.kinvardbio.com  (“Website”), why we collect it, and our practices for collecting, using, maintaining, protecting, and disclosing that information.

This Website Privacy Policy also addresses the options you have to access and control any personal information we collect from you or that you provide to us.

Please read this Website Privacy Policy carefully to understand our policies and practices regarding your information and how we will treat it.  If you do not agree with our policies and practices, do not use our Website.  By using our Website, you agree to this Website Privacy Policy.

The Website may include links to third-party websites, plug-ins, services, social networks, or applications. Clicking on those links or enabling those connections may allow the third party to collect or share information about you. If you follow a link to a third-party website or engage a third-party plugin, please note that these third parties have their own privacy policies and we do not accept any responsibility or liability for these policies. We do not control these third-party websites, and we encourage you to read the privacy policy of these third parties.

We may periodically make changes to this Website Privacy Policy. We encourage you to visit this page often, as it is your responsibility to review this Website Privacy Policy and remain informed about any changes.

Information We Collect About You and How We Collect It

We collect several types of information from and about users of our Website, including information that may personally identify you, such as name, address, e-mail address, telephone number, or other information that you may provide to us, as well as information about your internet connection, the equipment you use to access our Website, and usage details.

We collect this information directly from you when you provide it to us and automatically as you navigate through the site.  Information collected automatically may include usage details, IP addresses, and information collected through cookies or other tracking technologies as described below.

We will not sell your personal information and will use and disclose it only as described in this Website Privacy Policy

Information You Provide to Us

The information we collect through our Website may include:

  • Information that you provide by filling in forms on our Website, including contact information, professional information, file uploads, or publicly available reviews and comments.
  • Records and copies of correspondence if you contact us.
  • Your search queries on the Website.

Information We Collect Automatically

As you access and use our Website, we and our vendors may use analytics tools and other third-party technologies to collect some information automatically, including information about your equipment, browsing actions, and patterns, such as IP address, traffic data, location data, browser type and language, and referral website.  This information helps us to improve how our Website, provides services to you, and create and distribute marketing materials

The technologies we use for this automatic data collection may include cookies, pixels, and other tools used by our third-party vendors. Cookies are very tiny text files that are stored on your computer when you visit certain web pages and can be used to record your preferences. You may refuse to accept browser cookies by activating the appropriate setting on your browser.  However, if you select this setting, you may be unable to access certain parts of our Website.

Retention Periods

We retain the minimum level of information for as long as reasonably necessary for such information’s intended use. Once the intended retention period has passed, the information is to be deleted or modified such that it is no longer personal information. Information collected and stored by our service providers may be retained for different time periods.

Under some circumstances we may anonymize your personal information so that it can no longer be associated with you. We reserve the right to use such anonymous and de-identified data for any legitimate business purpose without further notice to you or your consent.

Children

It is our policy that we do not intend to collect, and we will not knowingly collect, personal information from children under the age of 13.  If we learn we have collected or received personal information from a child under 13 without verification of parental consent, we will delete that information. If you believe we might have any information from or about a child under 13, please contact us via e-mail at info@kinvardbio.com.

How We Use Your Information

We may use information collected from our Website and that you provide to us to:

  • Operate, manage, and improve our Website and present its contents to you.
  • Provide you with information, products, or services that you request from us.
  • Address any question, comment, or related request that you submit to us.
  • Communicate with you about our Website, products, and services, including the distribution of marketing and promotional materials and communications.
  • Prevent unauthorized, improper, fraudulent, or illegal activity.
  • For any other purpose with your consent.

How We Disclose Your Information

We may disclose information collected from our Website and that you provide to us to:

  • Our subsidiaries and affiliates.
  • Contractors, service providers, and other third parties we use to support our business and who are bound by contractual obligations to keep personal information confidential and use it only for the purposes for which we disclose it to them.
  • A buyer or other successor in the event of a merger, divestiture, restructuring, reorganization, dissolution, or other sale or transfer of some or all of our assets.
  • Comply with any court order, law, or legal process, including to respond to any government or regulatory request.
  • Protect or defend our rights, property, or safety, as well as those of our customers or others.
  • With your consent.

Your Rights

Depending on where you reside, in addition to any of the general rights you may have under this Website Privacy Policy, you may have the following rights associated with the personal information that we process:

  • Confirm whether we process your personal information.
  • Request access, correction, deletion, updates, or portability to certain of your personal information that we hold.
  • Object, restrict, or limit the ways in which we use or process your personal information.
  • Opt-out of marketing communication, promotional offers, or advertising.
  • Where we collect personal information based on your consent, you can withdraw your consent to our collecting, using, and sharing your personal information.

To submit a request to exercise these or other rights, or if you have a complaint about our privacy practices, you may contact us via e-mail at info@kinvardbio.com.  We will respond to your request within a reasonable time and in accordance with any deadline imposed by law and assist anyone who needs assistance preparing a request for access.  You also have the right to submit a complaint to your local data protection authority.

How We Protect Your Information

We have implemented reasonable and appropriate measures designed to help safeguard your personal information from unauthorized access, use, destruction, alteration, and disclosure.

Unfortunately, the transmission of information via the internet is not completely secure. Although we follow reasonable and appropriate measures to protect your personal information, we cannot guarantee the security of your personal information transmitted online. Any transmission of personal information is at your own risk. We urge you to be careful when accessing and sharing information online.

Contact Us

If you have any questions or requests related to this Website Privacy Policy or our privacy practices, you may contact us via e-mail at info@kinvardbio.com.

References

  • 01
    Ikuta, Kevin S, Lucien R Swetschinski, Gisela Robles Aguilar, Fablina Sharara, Tomislav Mestrovic, Authia P Gray, Nicole Davis Weaver, et al. ‘Global Mortality Associated with 33 Bacterial Pathogens in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019’. The Lancet 400, no. 10369 (December 2022): 2221–48. https://doi.org/10.1016/S0140-6736(22)02185-7
  • 02
    Tang, Ka Wah Kelly, Beverley C. Millar, and John E. Moore. “Antimicrobial Resistance (AMR).” British Journal of Biomedical Science. Institute of Biomedical Science (IBMS), 2023 https://doi.org/10.3389/bjbs.2023.11387
  • 03
    2023 Antibacterial Agents in Clinical and Preclinical Development an Overview and Analysis,” 2024 https://www.who.int/publications/i/item/9789240094000
  • 04
    Korang, Steven Kwasi, Chiara Nava, Sutharshini Punniyamoorthy Mohana, Ulrikka Nygaard, and Janus C. Jakobsen. “Antibiotics for Hospital-Acquired Pneumonia in Neonates and Children.” The Cochrane Database of Systematic Reviews. NLM (Medline), November 2, 2021 https://doi.org/10.1002/14651858.CD013864.pub2
  • 05
    Ferreira-Coimbra Cristina Sarda Jordi Rello, João. “Burden of Community-Acquired Pneumonia and Unmet Clinical Needs.” Advances in Therapy 37 (n.d.) https://doi.org/10.6084/m9.figshare.11673588
  • 06
    Julio A Ramirez, MD, FACP. “Overview of Community-Acquired Pneumonia in Adults,” January 2025 https://www.uptodate.com/contents/overview-of-community-acquired-pneumonia-in-adults
  • 07
    “Community Acquired Bacterial Pneumonia (CABP) Treatment Market 2023-2033,” March 2023 https://www.futuremarketinsights.com/reports/community-acquired-bacterial-pneumonia-treatment-market
  • 08
    Community-Acquired Bacterial Pneumonia Treatment Market 2030 – $2.67 Billion Revenue Forecast | GPR,” February 27, 2023 https://www.growthplusreports.com/report/community-acquired-bacterial-pneumonia-treatment-market/8290
  • 09
    Yang, Xiaorong, Hui Chen, Yue Zheng, Sifeng Qu, Hao Wang, and Fan Yi. “Disease Burden and Long-Term Trends of Urinary Tract Infections: A Worldwide Report.” Frontiers in Public Health 10 (July 27, 2022): 888205 https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.888205/full
  • 10
    RWE analysis from Optum insurance claims database: Calculated median charge per day of therapy in primary diagnosis UTI patients; $21,290 = Median Charge for UTI hospitalization in sample population 
  • 11
    Castanheira, Mariana, Lalitagauri M. Deshpande, Rodrigo E. Mendes, Rafael Canton, Helio S. Sader, and Ronald N. Jones. “Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program.” Open Forum Infectious Diseases 6 (March 15, 2019): S23-33 https://doi.org/10.1093/ofid/ofy347
  • 12
    Lodise, Thomas P., Teena Chopra, Brian H. Nathanson, and Katherine Sulham. “Hospital Admission Patterns of Adult Patients with Complicated Urinary Tract Infections Who Present to the Hospital by Disease Acuity and Comorbid Conditions: How Many Admissions Are Potentially Avoidable?” American Journal of Infection Control 49, no. 12 (December 1, 2021): 1528–34 https://doi.org/10.1016/j.ajic.2021.05.013
  • 13
    Bents, S.J., Mercaldo, R.A., Powell, C. et al. Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010–2019. BMC Infect Dis 24, 1094 (2024) https://doi.org/10.1186/s12879-024-09965-y
  • 14
    Zhou, Yunchun, Wei Mu, Jihua Zhang, Shi Wu Wen, and Smita Pakhale. “Global Prevalence of Non-Tuberculous Mycobacteria in Adults with Non-Cystic Fibrosis Bronchiectasis 2006-2021: A Systematic Review and Meta-Analysis.” BMJ Open. BMJ Publishing Group, August 1, 2022 https://doi.org/10.1136/bmjopen-2021-055672
  • 15
    Diel, Roland, Marc Lipman, and Wouter Hoefsloot. “High Mortality in Patients with Mycobacterium Avium Complex Lung Disease: A Systematic Review.” BMC Infectious Diseases 18, no. 1 (May 3, 2018) https://doi.org/10.1186/s12879-018-3113-x
  • 16
    Kwon, Byoung Soo, Tae Sun Shim, and Kyung Wook Jo. “The Second Recurrence of Mycobacterium Avium Complex Lung Disease after Successful Treatment for First Recurrence.” European Respiratory Journal. European Respiratory Society, January 1, 2019 https://publications.ersnet.org/content/erj/53/1/1801038